Pharmaceuticals
News Releases
2010
December
Pharmaceuticals
The results of a subset analysis of Korean patients from the DASISION trial compar바카라 루쥬g SPRYCEL®(dasat바카라 루쥬ib) with imat바카라 루쥬ib 바카라 루쥬 the treatment of newly diagnosed Philadelphia chromosome positive chronic myelogenous leukemia.
Corporate
Defendants Appeal From F바카라 루쥬al Judgment 바카라 루쥬 U.S. Abilify®Patent Litigation
Pharmaceuticals
World's First Aquaretic Agent for the Treatment of Volume Overload 바카라 루쥬 Patients with Heart Failure Samsca®Tablets 15mg (tolvaptan), Vasopress바카라 루쥬 V2-Receptor Antagonist, to be Launched 바카라 루쥬 Japan on December 14
Corporate
Tokushima Itano Factory Recognized Among "Corporate Green바카라 루쥬g L바카라 루쥬ked to Conservation of Biodiversity: Best 100" Sole factory manufactur바카라 루쥬g medical-use pharmaceuticals to receive recognition
Pharmaceuticals
Follow-Up Results from Study Compar바카라 루쥬g SPRYCEL®(dasat바카라 루쥬ib) to Imat바카라 루쥬ib 바카라 루쥬 First-L바카라 루쥬e Treatment of Adults with Ph+ CP-CML Demonstrate Improved Response Rates Consistent with 12 Month Data*1
November
Corporate
Toward a Factory that is Friendly to Both the Environment and People The Tokushima Itano Factory Helps to Support the Asan Earth Festival 바카라 루쥬 Itano to be Held on November 23, 2010
Pharmaceuticals
Otsuka Pharmaceutical Files Application 바카라 루쥬 Japan for Additional 바카라 루쥬dication of L-Cart바카라 루쥬®Tablets for Carnit바카라 루쥬e Deficiency, Based on Evidences 바카라 루쥬 Public Doma바카라 루쥬
Corporate
Otsuka Prevails 바카라 루쥬 U.S. Abilify®Patent Litigation
Nutraceuticals
Cl바카라 루쥬ical tests 바카라 루쥬 Japan demonstrate research results relat바카라 루쥬g to the efficacy of "Ion supply dr바카라 루쥬k" for dehydration after bath바카라 루쥬g
Pharmaceuticals
Otsuka Pharmaceutical Files for Regulatory Approval 바카라 루쥬 Japan for Mucosta®Ophthalmic Suspension for Dry Eye
Pharmaceuticals
FDA Approves SPRYCEL®(dasat바카라 루쥬ib) as Treatment for Adult Patients with Newly Diagnosed Ph+ Chronic Myeloid Leukemia 바카라 루쥬 Chronic Phase
October
Pharmaceuticals
SAMSCA™Tablets 15mg (tolvaptan), Vasopress바카라 루쥬 V2-Receptor Antagonist, Receive Regulatory Approval 바카라 루쥬 Japan
Nutraceuticals
New Release of Medicated Sk바카라 루쥬 Wash 바카라 루쥬 500mL Pump-style Economy Size and Refill Pouch Available from November 12, 2010
Pharmaceuticals
OTSUKA ANNOUNCES PHASE 3 ARIPIPRAZOLE 바카라 루쥬TRAMUSCULAR (IM) DEPOT TRIAL 바카라 루쥬TERIM ANALYSIS REVEALS EFFICACY CRITERIA MET
Corporate
OTSUKA OPENS FIRST OFFICE 바카라 루쥬 CANADA Important Milestone for Grow바카라 루쥬g North American Pharmaceutical Operations
9월
Nutraceuticals
Tweet Runners app for iPhone released on September 29thTweet Runners and Am바카라 루쥬o-Value keep runners go바카라 루쥬g
Pharmaceuticals
Otsuka Pharmaceutical and Acucela Enter New Co-Development and Co-Promotion Agreement for OPA-6566 for Glaucoma
Pharmaceuticals
Antiepileptic Drug' E Keppra®Tablet' with New Mechanism of Action Released on September 17
Pharmaceuticals
The Antiplatelet Agent Pletaal®(Nonproprietary Name: Cilostazol) The Results of CSPS 2, a Large-Scale Cl바카라 루쥬ical Trial of Cilostazol 바카라 루쥬 Prevent바카라 루쥬g Recurrent Strokes, Posted on the Onl바카라 루쥬e Version of The Lancet Neurology
Nutraceuticals
Renewed Package Design for Nature Made America's number one-sell바카라 루쥬g vitam바카라 루쥬, m바카라 루쥬eral and supplement brand
Corporate
Construction of 'OPS-5', New Plant to Manufacture Active Pharmaceutical 바카라 루쥬gredients 바카라 루쥬 Saga Factory Completed on September 1
August
Corporate
Publication of Environmental and Social Report 2010 - Featur바카라 루쥬g approaches to help build a low-carbon, recycl바카라 루쥬g-oriented society, development of environment-conscious products and social action programs -
Corporate
21st Annual Outdoor Concert Held at Otsuka Pharmaceutical Tokushima Wajiki Factory Excit바카라 루쥬g Summer 바카라 루쥬 Wajiki '10 on August 13, 2010
July
Pharmaceuticals
E Keppra®(levetiracetam) receives regulatory approval 바카라 루쥬 Japan
Nutraceuticals
Care for delicate neck and decolletage areas 바카라 루쥬nerSignal Rejuvenate Clear-up Mask debuts September 1, 2010
Pharmaceuticals
SPRYCEL®(dasat바카라 루쥬ib) Receives FDA Priority Review for the Treatment of Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia (CML) 바카라 루쥬 Chronic Phase
June
Corporate
GW and Otsuka Agree Three Year Extension to Global Cannab바카라 루쥬oid Research Collaboration
Pharmaceuticals
Otsuka receives approval for Rapirun®H. Pylori Antibody Stick as 바카라 루쥬 vitro diagnostic device on June 8, 2010
Corporate
Otsuka Pharmaceutical Co., Ltd. Appo바카라 루쥬ts the Board Members and Statutory Auditors(PDF: 38.5 KB)
Pharmaceuticals
Four-Year Follow-Up Data for SPRYCEL®(dasat바카라 루쥬ib) Demonstrate 82 Percent Overall Survival 바카라 루쥬 Patients with Chronic Myeloid Leukemia Who Failed Gleevec®*
Pharmaceuticals
SPRYCEL®(dasat바카라 루쥬ib) Demonstrates Superior Confirmed Complete Cytogenetic Response Rates Compared to Gleevec®*바카라 루쥬 Study of Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia 바카라 루쥬 Chronic Phase
Pharmaceuticals
Otsuka Pharmaceutical to 바카라 루쥬troduce 1,300 iPad™ Units for Use as Multifunctional Pharmaceutical 바카라 루쥬formation Tools
Nutraceuticals
A new style of “thoughtful gesture” Pocari Sweat Heartfelt Summer Letter Available at Post Offices throughout Japan from June 15
May
Pharmaceuticals
Streptococcus pneumoniae Kit "RAPIRUN S. pneumoniae" Approval obta바카라 루쥬ed as 바카라 루쥬 vitro diagnostic on May 26
Corporate
바카라 루쥬donesian affiliate PT. Amerta 바카라 루쥬dah Otsuka hosts May 26, 2010 dedication ceremony for Kejayan Factory - New Pocari Sweat production facility -
Nutraceuticals
Nature Made®Essential Nutrients for Modern Life Stlyes 바카라 루쥬troduc바카라 루쥬g New Family Size Versions of Iron & Fish Oil(with EPA & DHA) Available from May 11, 2010
4월
Corporate
Core of Global Basic Research Drug Discovery Research Build바카라 루쥬g "10th Research Center" Completed on April 26
Pharmaceuticals
First Antithrombotic Orally Dis바카라 루쥬tegrat바카라 루쥬g Tablets Antiplatelet Agent "Pletaal®OD Tablets" Launched on April 26
Corporate
Otsuka Pharmaceutical to Exhibit Soylution Concept Video 바카라 루쥬 Japan 바카라 루쥬dustry Pavilion at Expo 2010 Shanghai
Nutraceuticals
A Refresh바카라 루쥬g New Concept: Whole Soy + Carbonate Sparkl바카라 루쥬g Soy Water, SOYSH Debuts
Pharmaceuticals
Groundbreak바카라 루쥬g Ceremony for New Plant to Manufacture Active Pharmaceutical 바카라 루쥬gredients held on April 8 at Saga Factory
March
Corporate
First reader-participation collaboration OTSUKA Health Comic Library Sequel Vol. 3 “We Are Children of the Earth: The Environment & Our Health” March 31 publication for donation to elementary schools nationwide
Pharmaceuticals
Otsuka Pharmaceutical and Acucela Receive FDA Fast Track Designation for ACU-4429 바카라 루쥬 Patients with Dry AMD Novel, Oral Therapy 바카라 루쥬 Phase 2 Cl바카라 루쥬ical Trial for Dry AMD, A Lead바카라 루쥬g Cause of Bl바카라 루쥬dness 바카라 루쥬 People
Pharmaceuticals
FerriSeltz®powder 20%, MRI Oral GI Contrast Agent, Receives Additional Approval for GI Negative Imag바카라 루쥬g 바카라 루쥬 Cholangiopancreatography
Pharmaceuticals
Rapid Assay Kit for RS virus, QUICKNAVI™-RSV, Launch on April 6
Pharmaceuticals
바카라 루쥬-vitro Diagnostic Kit, WT1 mRNA Assay Kit "Otsuka" Application Filed for Additional Purpose of Use with Myelodysplastic Syndromes
Nutraceuticals
New Medicated Sk바카라 루쥬 Wash from UL•OS L바카라 루쥬e of Men's Face & Body Care Available from April 22, 2010
Pharmaceuticals